| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | GENPAC HOLDINGS INC. CMN | May 28, 2024 | |
| Buy | GENPACT LTD | Nov 1, 2023 | |
| Buy | GENPACT LTD | Oct 5, 2023 | |
| Buy | GENPACT LTD | Aug 25, 2023 | |
| Sell | GENPACT LTD | May 4, 2023 | |
| Buy | GENERAC HOLDINGS INC. CMN | Apr 25, 2023 | |
| Sell | GENPAC HOLDINGS INC. CMN | Nov 3, 2022 | |
| Sell | Generac Holdings Inc. common | Oct 11, 2022 | |
| Buy | Genpact Holdings Inc. common | Sep 28, 2022 | |
| Buy | Genpro Holdings Inc. common | Sep 28, 2022 |
This page tracks congressional stock trading activity in Genpact Limited (G) in the Technology sector. Disclosed Capitol has indexed 32 disclosed congressional trades involving G. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of June 2024 — Disclosed Capitol has tracked 32 disclosed congressional trades in Genpact Limited (G) — 14:14 buy-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 28, 2024 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Nov 1, 2023 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Oct 5, 2023 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| Aug 25, 2023 | Michael McCaul | R | Purchase | $1,001 - $15,000 |
| May 4, 2023 | Michael McCaul | R | Exchange | $1,001 - $15,000 |
| Apr 25, 2023 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Nov 3, 2022 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Oct 11, 2022 | Thomas Suozzi | D | Sale | $50,001 - $100,000 |
| Sep 28, 2022 | Thomas Suozzi | D | Purchase | $15,001 - $50,000 |
| Sep 28, 2022 | Thomas Suozzi | D | Purchase | $15,001 - $50,000 |
Across the 32 disclosed congressional trades in Genpact Limited (G), members of Congress have reported 14 buys and 14 sells. The average 30-day alpha vs. the S&P 500 is -0.67%.
For fiscal year 2025, Genpact Limited reported revenue of $5.08B and net income of $552.5M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.34B, net income $145.7M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.